Skip to content

A National Study of Intravenous Medication Errors

A National Study of Intravenous Medication Errors: Understanding How to Improve Intravenous Safety With Smart Pumps

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02359734
Enrollment
900
Registered
2015-02-10
Start date
2012-04-30
Completion date
2015-12-31
Last updated
2016-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Administered in Error

Keywords

Patient safety, Medication errors, Smart infusion pump

Brief summary

To identify the key issues around use of computerized patient infusion devices (called smart pumps). To develop strategies that will improve the prevention of intravenous errors that will be broadly applicable. The investigators will conduct a national study using the general methodology developed by Husch et al. to allow a rapid assessment of the frequency and types of medication errors at an institution. The key questions the investigators will address are: 1. What are the frequency and types of intravenous medication errors? 2. How much variability is there by frequency and type among settings? 3. After review of the initial data, what strategies appear to have the greatest potential for reducing intravenous medication error frequency? 4. How effective is an intervention including a bundle of these strategies at multiple sites?

Detailed description

Overall Study Design: This is a multi-hospital study to investigate medication errors using smart pumps. The proposed study will be conducted over three phases for a total of 36 months phases. In Year 1, an observational study will be conducted by investigators at ten multiple hospital sites. The investigators will prospectively compare the medication, dose, and infusion rate on the IV pump with the prescribed medication, doses, and rate in the medical record. Preventability with smart pump technology will be retrospectively determined based on a rigorous definition of currently available technology. The investigators will also make comparisons across sites by overall rate and degree of variability among sites. Then, in Year 2, these results will be evaluated, and a consensus process including a face-to-face meeting will take place to evaluate the types of events and to develop an intervention which will be implemented at multiple sites. After a run-in period, the intervention will be tested in Year 3 at the sites, and the data will be analyzed, and the investigators will produce a report and a set of recommendations.

Interventions

OTHERSmart pump safety Intervention bundle for improving IV medication administration process with smart pump

Smart pump safety intervention bundle includes three components--1) eliminating unauthorized medications; implement standardized discontinuation policy of medications, implement standardized keep vein open rates and keep vein open rate order sets, and implement standardized verbal order practice. 2) Implement standardized intravenous(IV) labeling and IV tubing labels. 3) Implement standardized drug library lists and drug library use policies

Sponsors

Johns Hopkins University
CollaboratorOTHER
Winchester Medical Center
CollaboratorOTHER
Central DuPage Hospital
CollaboratorOTHER
Vanderbilt University
CollaboratorOTHER
Massachusetts General Hospital
CollaboratorOTHER
University of California, San Diego
CollaboratorOTHER
Valleywise Health
CollaboratorOTHER
Danbury Hospital
CollaboratorOTHER
Association for the Advancement of Medical Instrumentation
CollaboratorOTHER
CareFusion foundation
CollaboratorUNKNOWN
Candler Hospital
CollaboratorUNKNOWN
Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients if they receive any IV fluid or medication on the day of observation in the study units.

Exclusion criteria

* patients who are under 21 years old.

Design outcomes

Primary

MeasureTime frameDescription
Higher-severity medication errorsTwo yearsAll medication errors with an NCC MERP severity rating of C or greater (excluding violation of hospital policy errors;outcome 12 and 13).
Compliance rate of IV tubing not tagged according to policyTwo yearsIV tubing change label is not tagged per institution policy.
Incident rates of expired drugTwo yearsThe expiration date or time of the fluids/medications has passed.
Overall medication errorsTwo yearsTotal number of all observed medication errors(including outcome 1-14)
Incident rates of wrong doseTwo yearsThe same medication but the dose is different from the prescribed order.
Incident rates of wrong rateTwo yearsA different rate is displayed on the pump from that prescribed in the medical record. Also refers to weight based doses calculated incorrectly including using a wrong weight.
Incident rates of wrong concentrationTwo yearsAn amount of a medication in a unit of solution that is different from the prescribed order.
Incident rates of wrong IV fluids/medicationsTwo yearsA different fluid/medication as documented on the IV bag label is being infused compared with the order in the medical record.
Incident rates of delay of medication administrationTwo yearsAn order to start or change medication or rate not carried out within 4 hours of the written order or intended start time per institution policy.
Incident rates of omission of IV fluids/medicationsTwo yearsThe medication ordered was not administered to a patient or administered anytime after 4 hours of the intended start time.
Incident rates of unauthorized medicationTwo yearsFluids/medications are administered to the patient but no order is present in medical record. This includes failure to document a verbal order.
Incident rates of patient identification (ID) error (wrong patient)Two yearsPatient either has no ID band on or information on the ID band or label is incorrect.
Incident rates of smart pump or drug library not usedTwo yearsSmart pump is not used (bypassing smart pump) or smart pump was used but the drug library was not selected, rather manual entry mode was used (bypassing drug library)
Incident rates of oversight allergyTwo yearsMedication is administered to a patient with a known allergy to the drug or class.
Incident rates of pump setting errorTwo yearsSetting programmed into the pump is different from the prescribed order.
Compliance rate of label not complete according to policyTwo yearsDocumented information on the medication label is different from required information per institution policy.

Secondary

MeasureTime frameDescription
Compliance rate of using drug library useTwo yearsCompliance rate of using drug library
Potential adverse drug eventsTwo yearsMedication errors with potential for harm categorized as D (errors that would have required increased monitoring to preclude harm) or higher by NCC MERP Index
Compliance rate of using smart pump useTwo yearsCompliance rate of using smart pump

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026